Trial intelligence / Profile preview

Neuroadaptations to Very Low Nicotine Content Cigarettes

NCT03612960Completed

Sponsor
Penn State Health Milton S. Hershey Medical Center
Start
Feb 2020
Primary completion
Jun 2023
Countries
1
01

Overview

Randomised, double-blind trial (2 arms), sponsored by Penn State Health Milton S. Hershey Medical Center. Primary endpoint: Change in Blood Oxygen Level Dependent (BOLD) Signal During Monetary Delay Discounting Task at 6 weeks. Started Feb 2020; status: completed.

Beyond the preview

Go deeper on NCT03612960.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03612960.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call